A novel gastrointestinal microbiome modulator from soy pods reduces absorption of dietary fat in mice

Obesity

Volumn 24, Issue 1, 2016, Pages 87-95

  Boué, Stephen ^a   Fortgang, Ilana ^b   Levy, Ronald J ^c   Bhatnagar, Deepak ^a   Burow, Matthew ^b   Fahey, George ^d   Heiman, Mark L ^e  

^a SOUTHERN REGIONAL RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Louisiana State University at Alexandria   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e MicroBiome Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CXCL1 CHEMOKINE; GLUCOSE; INTERLEUKIN 10; LACTIC ACID; SHORT CHAIN FATTY ACID; TRIACYLGLYCEROL; FAT INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; FECES MICROFLORA; INTESTINE FLORA; LIPID ABSORPTION; MALE; MOUSE; NONHUMAN; SOY FOOD; ANIMAL; C57BL MOUSE; CALORIC INTAKE; CHEMISTRY; DIET THERAPY; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; FECES; INTESTINE ABSORPTION; METABOLISM; MICROBIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACOKINETICS; PHYSIOLOGY; SECRETION (PROCESS); SOYBEAN;

ANIMALS; BILE ACIDS AND SALTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; ENERGY INTAKE; FECES; GASTROINTESTINAL MICROBIOME; INTESTINAL ABSORPTION; MALE; MICE; MICE, INBRED C57BL; SOYBEANS; TRIGLYCERIDES;

EID: 84951907916     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21197     Document Type: Article

References (39)

1. The Human Microbiome Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
2. The metaHIT Consortium. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014; 32: 834-841.
3. Ridaura UK, Faith JJ, Rey FE, et al., Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241214
4. Gu L, Gu W., Characterisation of soy isoflavones and screening for novel malonyl glycosides using high-performance liquid chromatography-electrospray ionisation-mass spectrometry. Phytochem Anal 2001; 12: 377-382.
5. Zimmerman MC, Tilghman SL, Boué SM, et al., Glyceollin I, a novel phytoalexin isolated from activated soy. J Pharmacol Exper Ther 2010; 332: 35-45.
6. Boué SM, Isakova IA, Burow ME, et al., Glyceollins, soy isoflavone phyoalexins, improve oral glucose disposal by stimulating glucose uptake. J Agric Food Chem 2012; 60: 6376-6382.
7. Wood CE, Clarkson TB, Appt SE, et al., Interactive effects of soybean glyceollins and estradiol in the breast. Nutr Cancer 2006; 56: 74-81.
8. Smiricky-Tjardes MR, Grieshop CM, Flickinger EA, Bauer LL, Fahey GC Jr., Dietary galactooligosaccharides affect ileal and total-tract nutrient digestibility, ileal and fecal bacterial concentrations, and ileal fermentative characteristics of growing pigs. J Anim Sci 2003; 81: 2535-2545.
9. AOAC. 2005. Association of Official Agricultural Chemists, Official Methods of Analysis of AOAC International. Arlington: AOAC International; 2005.
10. Hernot DC, Boileau TW, Bauer LL, et al., In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose. J Agric Food Chem 2009; 57: 1354-1361.
11. Ridlon JM, Kang D-J, Hylemon PB., Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47: 241-259.
12. Marks S., The role of orlistat in weight management. Aust Fam Physician 2001; 30: 335-338.
13. Jung UJ, Lee M-K, Park YB, Kang MA, Choi MS., Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol 2006; 38: 1134-1145.
14. Rabo S, Membrez M, Bruneau A, et al., Germ-free C57Bl/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J 2010; 24: 4948-4959.
15. Goodwin B, Jones SA, Price RR, et al., A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6: 517-526.
16. Lu TT, Makishima M, Repa JJ, et al., Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000; 6: 507-515.
17. Sayin SI, Waström A, Felin J, et al., Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17: 225-235.
18. Hashidume T, Sasaki T, Inoue J, Sato R., Consumption of soy protein isolate reduces SERBP-1c and lipogenic gene expression in wild-type mice, but not in FXR-deficient mice. Biosci Biotechnol Biochem 2011; 75: 1702-1707.
19. Larkin T, Price WE, Astheimer L., The key importance of soy isoflavone bioavailability to understanding health benefits. Crit Rev Food Sci Nutr 2008; 48: 538-552.
20. Rickettsa M-L, Moorea DD, Banzb WJ, Mezei O, Shay NF., Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 2005; 16: 321-330.
21. Jones BV, Beglev M, Hill C, Gahan CG, Marchesi JR., Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA 2008; 105: 13580-13585.
22. Parks BW, Nam E, Org E, et al., Genetic control of obesity and gut microbiota composition in response to high-fat, high sucrose diet in mice. Cell Metab 2013; 17: 141-152.
23. Islam KB, Fukiya S, Hagio M, et al., Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011; 141: 1773-1781.
24. Shin N-R, Lee J-C, Lee H-Y, et al., An increase in the Akkermansia spp. Population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014; 63: 727-735.
25. Everard A, Lazarevic V, Derrien M, et al., Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011; 60: 2775-2786.
26. Renouf M, Hendrich S., Bacteroides uniformis is a putative bacterial species associated with degradation of the isoflavone genistein in human feces. J Nutr 2011; 141: 1120-1126.
27. Baer DJ, Stote KS, Henderson T, et al., The metabolizable energy of dietary resistant maltodextrin is variable and alters fecal microbiota composition in adult men. J Nutr 2014; 144: 1023-1029.
28. Ducs FA, Sakar Y, Lepage P, et al., Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats. Diabetes 2014; 63: 1624-1636.
29. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA., Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism 2013; 4: 42.
30. Finegold SM, Dowd SE, Gontcharova V, et al., Pyrosequencing study of fecal microlora of autistic and control children. Anaerobe 2010; 16: 444-453.
31. Stack N, Mueller K, Schemann M, Haller D., Bacterial proteases in IBD and IBS. Gut 2012; 61: 1610-1618.
32. Kaur N, Chen CC, Luther J, Kao JY., Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes 2011; 2: 211-216.
33. Saulnier DM, Riehle K, Mistretta TA, et al., Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1782-1791.
34. Chassaing B, Koren O, Goodrich JK, et al., Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519: 92-96.
35. Martin GP, Marriott C, Kellaway IW., Direct effect of bile salts and phospholipids on the physical properties of mucus. Gut 1978; 19: 103-107.
36. Nevrinck AM, Van Hée VF, Piront N, et al., Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr Diabetes 2012; 2: e28.
37. Kim HJ, Sung M-K, Kim J-S., Anti-inflammatory effects of glyceollins derived from soybean by elicitation with Aspergillus sojae. Inflamm Res 2011; 60: 909-917.
38. Ku WL, Lee S-K, Bae Y-M, Jong-Sup B., Anti-septic effects of glyceollins in HMGB-1-induced inflammatory responses in vitro and in vivo. Food Chem Toxicol 2014; 63: 108.
39. García-Lafuente A, Guillamõn E, Villares A, Rostagno MA, Martínez JA., Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 2009; 58: 537-552.